ascopubs.org

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma Allogeneic hematopoietic stem cell ...
ascopubs.org

Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter ...

Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study) The aim of this open-label, ...
EurekAlert!

USTC discovers new strategy for preventing acute graft-versus-host disease

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a critical therapeutic strategy for treating conditions such as hematological malignancies, bone marrow failure syndromes, and ...
The American Journal of Managed Care

Reduced Rehospitalizations and Potential Cost Savings With Orca-T for Acute Leukemia, MDS: Caspian Oliai, MD, MS

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...
MedPage Today

Nutritional Challenges in Childhood HSCT Survivors

Most of the 85 study participants, who were a median age of 30 years old, failed to meet established nutritional recommendations. Still, no significant associations were found between micronutrient ...
EurekAlert!

Tackling infections in pediatric HSCT: A risk-adapted approach

Revised algorithm for prophylactic antimicrobials and infection monitoring. ADV, adenovirus; BKV, BK virus; CMV, cytomegalovirus; CMV D/R, cytomegalovirus donor ...